The role of EPAS1 polymorphisms on COPD susceptibility in southern Chinese
Author:
Wang Yunchao,
Lin AoORCID,
He Ruiqi,
Chen Cuiyi,
Zeng Xiaobin,
Pan Yujie,
Mao Chun,
Xie Chenli,
Huang Dongsheng,
Deng Yibin,
Zhang Xuhui,
Lu Jiachun,
Wang Xinhua
Subject
Multidisciplinary
Reference47 articles.
1. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Soriano;Lancet Respir. Med.,2020
2. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis;Adeloye;Lancet Respir. Med.,2022
3. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study;Wang;Lancet,2018
4. COPD: early diagnosis and treatment to slow disease progression;Welte;Int. J. Clin. Pract.,2015
5. The relationship between COPD and lung cancer;Durham;Lung Cancer,2015